PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
PRDS
Delisted
PRDS was delisted on the 30th of August, 2023.
69 hedge funds and large institutions have $144M invested in Pardes Biosciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
49% less capital invested
Capital invested by funds: $282M → $144M (-$139M)
Holders
69
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$18.9M | |
| 2 | +$6.64M | |
| 3 | +$3.87M | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$1.65M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$822K |
Top Sellers
| 1 | -$3.79M | |
| 2 | -$3.29M | |
| 3 | -$1.83M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.63M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.41M |